Saudi Food & Drug Authority (SFDA) records more than 30,000 applications via Saudi Drug Registration (SDR) System since the launch of its new version in mid-2021. SDR registered more than 8,000 medicinal, herbal and veterinary products, and issued more than 8,000 certificates.

Saudi Food and Drug Authority (SFDA) penalized 45 facilities during December 2022, due to lack of commitment to provide the registered pharmaceutical products to the local market, inform instantly to the movement of the drug in the electronic tracking system, and report on expected shortage or interruption in the supply of pharmaceutical products that have been registered with the Authority.

The Saudi Food and Drug Authority participates in the 6th annual meeting of the Saudi Pharmaceutical Society "SIPHA". The meeting is held in Dhahran under the patronage of His Royal Highness Prince Saud bin Naif, Governor of the Eastern Region, and in the presence of His Excellency the CEO of SFDA, Dr. Hisham bin Saad Aljadhey, during the period 3-5 January 2023.

His Excellency the CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham bin Saad Aljadhey, met today at the authority’s headquarters in Riyadh, His Excellency the Minister of Health of the Islamic Republic of Mauritania, Moktar Ould Dahi and his accompanying delegation, in the presence of the Ambassador of the Republic of Mauritania to the Kingdom Sidi Ali.

Saudi Food and Drug Authority (SFDA) has participated in the 45th semi-annual meeting of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH), which was held in Incheon, South Korea, with the participation of Saudi specialists and experts.